UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FDA Approval: Blinatumomab

Clinical cancer research, 2015-09, Vol.21 (18), p.4035-4039

2015

Volltextzugriff (PDF)

Damage associated molecular pattern molecules

Clinical immunology (Orlando, Fla.), 2007-07, Vol.124 (1), p.1-4

2007

Volltextzugriff (PDF)

An Adenoviral Vector Cancer Vaccine That Delivers a Tumor-Associated Antigen/CD40-Ligand Fusion Protein to Dendritic Cells

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.15101-15106

2003

Volltextzugriff (PDF)

Normal and Pathological Functions of Mammalian Retroelements

Proceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (35), p.12292-12293

Deisseroth, Albert

2005

Volltextzugriff (PDF)

Recent Advances and Current Challenges in Tumor Immunology and Immunotherapy

Molecular therapy, 2007-06, Vol.15 (6), p.1065-1071

2007

Volltextzugriff (PDF)

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

Journal of Virology, 2004-01, Vol.78 (1), p.116-123

2004

Volltextzugriff (PDF)

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

Investigative ophthalmology & visual science, 2004-07, Vol.45 (7), p.2407-2412

2004

Volltextzugriff (PDF)

Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial Neoplasms

Clinical cancer research, 2004-11, Vol.10 (22), p.7738-7746

2004

Volltextzugriff (PDF)

Methods for delivery of adenoviral vectors to tumor vasculature

Human gene therapy, 2007-02, Vol.18 (2), p.151-160

2007

Volltextzugriff (PDF)

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

Cancer gene therapy, 2003-05, Vol.10 (5), p.388-395

2003

Volltextzugriff (PDF)

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease

Clinical cancer research, 2015-03, Vol.21 (5), p.950-954

2015

Volltextzugriff (PDF)

Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer

Molecular cancer therapeutics, 2006-08, Vol.5 (8), p.1975-1985

2006

Volltextzugriff (PDF)

International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers

Cancer Immunology, Immunotherapy, 2006-11, Vol.55 (11), p.1406-1411

2006

Volltextzugriff (PDF)

Tumor vascular targeting therapy with viral vectors

Blood, 2006-04, Vol.107 (8), p.3027-3033

2006

Volltextzugriff (PDF)

Use of Adenoviral Vectors to Target Chemotherapy to Tumor Vascular Endothelial Cells Suppresses Growth of Breast Cancer and Melanoma

Molecular therapy, 2010-05, Vol.18 (5), p.921-928

2010

Volltextzugriff (PDF)

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged

Cancer Immunology, Immunotherapy, 2009-12, Vol.58 (12), p.1949-1957

2009

Volltextzugriff (PDF)

High and Low Levels of Cottontail Rabbit Papillomavirus E2 Protein Generate Opposite Effects on Gene Expression

The Journal of biological chemistry, 2001-01, Vol.276 (2), p.867-874

2001

Volltextzugriff (PDF)

Chemotherapy Targeted to Cancer Tissue Potentiates Antigen-specific Immune Response Induced by Vaccine for In Vivo Antigen Loading and Activation of Dendritic Cells

Molecular therapy, 2008-10, Vol.16 (10), p.1753-1760

2008

Volltextzugriff (PDF)

Vector Prime/Protein Boost Vaccine That Overcomes Defects Acquired during Aging and Cancer

Journal of Immunology, 2006-10, Vol.177 (8), p.5697-5707

2006

Volltextzugriff (PDF)

Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma

Human gene therapy, 2004-07, Vol.15 (7), p.637-647

2004

Volltextzugriff (PDF)

The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (11), p.4405

2001

Volltextzugriff (PDF)

A temperature‐sensitive mutant of human p53

The EMBO journal, 1994-06, Vol.13 (11), p.2535-2544

1994

Volltextzugriff (PDF)

Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens

Blood, 2004-11, Vol.104 (9), p.2704-2713

2004

Volltextzugriff (PDF)

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells

Oncogene, 1998-08, Vol.17 (7), p.825-833

1998

Volltextzugriff (PDF)

Human interferon regulatory factor 2 gene. Intron-exon organization and functional analysis of 5'-flanking region

The Journal of biological chemistry, 1994-02, Vol.269 (7), p.5279-5287

1994

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(42)
Humans
(38)
Mice
(31)
Biological And Medical Sciences
(19)
Female
(16)
Oncology
(15)
Medical Sciences
(12)
Adenoviridae - Genetics
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Genes
(8)
Immunology
(8)
Immunotherapy
(8)
Tumor Cells, Cultured
(8)
Biochemistry & Molecular Biology
(7)
Cell Line
(7)
Cell Lines
(7)
Gene Therapy
(7)
Genetic Vectors
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDA Approval: Blinatumomab

Damage associated molecular pattern molecules

An Adenoviral Vector Cancer Vaccine That Delivers a Tumor-Associated Antigen/CD40-Ligand Fusion Protein to Dendritic Cells

Normal and Pathological Functions of Mammalian Retroelements

Recent Advances and Current Challenges in Tumor Immunology and Immunotherapy

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial Neoplasms

Methods for delivery of adenoviral vectors to tumor vasculature

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease

Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer

International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers

Tumor vascular targeting therapy with viral vectors

Use of Adenoviral Vectors to Target Chemotherapy to Tumor Vascular Endothelial Cells Suppresses Growth of Breast Cancer and Melanoma

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged

High and Low Levels of Cottontail Rabbit Papillomavirus E2 Protein Generate Opposite Effects on Gene Expression

Chemotherapy Targeted to Cancer Tissue Potentiates Antigen-specific Immune Response Induced by Vaccine for In Vivo Antigen Loading and Activation of Dendritic Cells

Vector Prime/Protein Boost Vaccine That Overcomes Defects Acquired during Aging and Cancer

Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma

The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines

A temperature‐sensitive mutant of human p53

Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells

Human interferon regulatory factor 2 gene. Intron-exon organization and functional analysis of 5'-flanking region

Aktive Filter

Suchergebnisse filtern